346 top medical experts on Synucleinopathies across 44 countries and 28 U.S. states, including 172 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Synucleinopathies: Neurodegenerative disorders involving deposition of abnormal alpha-synuclein in dopaminergic neurons and glial cells in the brain. Pathological aggregations of alpha-synuclein proteins results in lewy bodies and Lewy neurites; melanin granules in the substantia nigra and locus coeruleus; and glial cytoplasmic inclusions. Synucleinopathies are associated with mutation in the alpha-synuclein (snca) gene on chromosome 4. parkinson disease; lewy body disease with dementia; and multiple system atrophy are prominent examples of synucleinopathy.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Neurodegenerative Diseases (2,937), Proteostasis Deficiencies (1,784) and Narrower Categories: Lewy Body Disease (2,176), Multiple System Atrophy (1,522), Parkinson Disease (5,032).
  4. Clinical Trials ClinicalTrials.gov : at least 11 including 1 Active, 4 Completed, 5 Recruiting
  5. Synonyms: a-Synucleinopathies,  alpha Synuclein Pathology,  alpha-Synucleinopathies


  

        

                    


    Computing Expert Listing ...

);